IVORX | VMVIX | IVORX / VMVIX | |
Total Expense Ratio | 1.33 | 0.19 | 700% |
Annual Report Gross Expense Ratio | 1.52 | 0.19 | 800% |
Fund Existence | 11 years | 19 years | - |
Gain YTD | 7.792 | 6.022 | 129% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 862M | 32.5B | 3% |
Annual Yield % from dividends | 1.11 | 2.05 | 54% |
Returns for 1 year | -5.36 | 0.89 | -601% |
Returns for 3 years | 23.08 | 35.65 | 65% |
Returns for 5 years | 36.61 | 62.54 | 59% |
Returns for 10 years | 97.42 | 98.70 | 99% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 48.20 | 0.19 | +0.40% |
SPDR® S&P Pharmaceuticals ETF | |||
MARB | 20.27 | 0.01 | +0.03% |
First Trust Merger Arbitrage ETF | |||
VSDM | 76.68 | 0.02 | +0.03% |
Vanguard Short Duration Tax-Exm Bd ETF | |||
AVSF | 47.29 | -0.03 | -0.06% |
Avantis Short-Term Fixed Income ETF | |||
ITA | 205.93 | -0.32 | -0.16% |
iShares US Aerospace & Defense ETF |